I totally agree. I don't think anything but some announcements regarding money and making money are going to shift the SP. No one seems interested in clinical results except people that are not influencing the SP. It's definitely a long game this one.
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves, page-4
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.80 |
Change
0.020(0.20%) |
Mkt cap ! $207.1M | |||
| Open | High | Low | Value | Volume |
| $9.85 | $10.78 | $9.60 | $572.9K | 57.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5627 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 931 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |